Home›Legal›Ipamorelin in California
Ipamorelin in California: Legal Status & Provider Guide (2026)
Quick Answer
Ipamorelin is a prescription substance in the United States. Ipamorelin is an unapproved research peptide with no FDA bulk compounding authorization. While it has been offered by compounding pharmacies under various interpretations, federal compliance risk is elevated. Patients should verify current regulatory standing with their provider. In California, compounding is governed by the California State Board of Pharmacy (CSBP). California allows nurse practitioners and physician assistants with standardized procedures or physician collaboration to prescribe compounded peptides. California's telehealth laws (AB 2019 and subsequent legislation) require an established patient-provider relationship before prescribing. Out-of-state prescribers cannot prescribe to California patients without a California license.
Federal Legal Status
FDA Approval Status
Not FDA-approved as a drug. Not on the FDA 503A or 503B bulk substances lists. Ipamorelin's compounding status is contested — it was removed from the 503A consideration list and faces similar restrictions to other unapproved peptides.
Compounding Pharmacy Rules (Federal)
Ipamorelin is not on the FDA-approved 503A or 503B bulk substances lists. Some compounding pharmacies have offered it historically, but FDA guidance suggests significant legal risk. Its status is often treated similarly to CJC-1295 and other non-listed peptides. Legal compounding under federal oversight is uncertain.
Also Known As
NNC 26-0161
Primary Research Areas
- Growth hormone stimulation
- Anti-aging
- Body composition
- Recovery
California Pharmacy Board & Compounding Rules
Compounding Overview
The California State Board of Pharmacy enforces strict compounding standards, often exceeding federal minimums. California has its own sterile compounding licensure category and requires all sterile compounding pharmacies to hold a specialty license. California pharmacies must comply with USP 797 (sterile) and USP 795 (non-sterile) standards. The California Medical Board also imposes strict telemedicine prescribing standards that affect peptide clinics operating as telehealth platforms serving California residents.
Notable Rules
- California requires a specialty sterile compounding license in addition to a standard pharmacy license.
- USP 797 and 795 compliance is mandatory for all California-licensed compounding pharmacies.
- The California Medical Board has specific guidance on prescribing practices for "off-label" and compounded medications.
- Out-of-state pharmacies must be licensed by CSBP to ship prescription compounds into California.
- California prohibits prescription dispensing without an established patient-provider relationship in most telehealth contexts.
Prescribing Requirements in California
California allows nurse practitioners and physician assistants with standardized procedures or physician collaboration to prescribe compounded peptides. California's telehealth laws (AB 2019 and subsequent legislation) require an established patient-provider relationship before prescribing. Out-of-state prescribers cannot prescribe to California patients without a California license.
About Ipamorelin
Ipamorelin is a selective growth hormone secretagogue (GHSR agonist) and a pentapeptide. It stimulates growth hormone release with reportedly high selectivity — less stimulation of cortisol and prolactin than earlier GHRPs. Most evidence comes from animal studies.
For more research information, mechanism of action, and provider availability, see the Ipamorelin research profile on PeptideBase.
Frequently Asked Questions
- Is ipamorelin legally available from compounding pharmacies?
- Ipamorelin is not on the FDA bulk substances lists for 503A or 503B compounding. Some pharmacies have offered it, but federal compliance is uncertain. The regulatory environment has tightened since 2021. Patients should ask their provider for explicit documentation of the legal basis.
Ipamorelin Providers in California
No providers currently listed in California for Ipamorelin. Browse the full directory to find providers offering Ipamorelin.
Browse all Ipamorelin providers →Ipamorelin Legal Status in Other States
Pharmacy board rules and compounding regulations vary by state. Compare Ipamorelin legal status across other major markets:
Content review: This educational overview is prepared by the PeptideBase editorial team and reviewed for factual accuracy. Reviewer byline coming soon (gated on 4.4). Last updated: .